Justin Ling: In 2019, Trudeau vowed to launch national universal pharmacare. This time around that pledge, along with plans for affordable drug pricing, has faded.
Ed Broadbent and Brittany Andrew-Amofah: To ‘build back better’ Canada will need childcare, pharmacare, a green recovery—and new measures to sustain them
Jane Philpott and Danyaal Raza: Medicare effectively ends as soon as a patient receives a prescription
Anne Kingston: These are still just recommendations. But now that the spotlight has turned on Medicare’s incomplete mandate, it will be difficult for politicians to step away.
Tom Parkin: Bill Morneau’s fall economic update gave big for business, and ignored a much bigger issue—crushing household debt
Three issues and one wild card will dominate the next election—and determine the fate of the Trudeau Liberals
Tom Parkin: If the NDP wins the Ontario election its plan to extend social programs could kick off a much needed new era in co-operative federalism
Opinion: There are 19 drugs on the Canadian market that cost $50,000 or more per year—a national pharmacare plan could ease the burden
A new advisory council is set to study national pharmacare. The NDP’s health critic says it’s redundant and ‘kicking the can down the road.’
Inequality, pharmacare and intraparty democracy were on the agenda at the NDP’s Ottawa convention. ‘The time for timid is over’, said Singh.
Brian Topp has released his sixth policy paper, this one on supporting families. He’s proposing a national child nutrition program, a renewed health accord, a national pharmacare plan, a reversal of the moratorium on family reunification, a doubled Canada Pension Plan and support for LGBTTQ families.
Marc-André Gagnon’s solution should be read by citizens of every political orientation